The Ocular Surface Characteristics in Prostate Cancer Patients Treated with Androgen Deprivation Therapy

Background.To investigate the association of long-term androgen deprivation therapy (ADT) with ocular surface characteristics in prostate cancer patients. Methods. A total of 30 male prostate cancer patients who received ADT were selected. All candidates were scored using the Ocular Surface Disease...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Weina Li, Xiaofeng Li, Feilun Cui, Zhipeng Xu, Nuo Dong, Cheng Li
Formato: article
Lenguaje:EN
Publicado: Hindawi Limited 2021
Materias:
Acceso en línea:https://doaj.org/article/d32ed25458984d0984e3aeaf961b65eb
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d32ed25458984d0984e3aeaf961b65eb
record_format dspace
spelling oai:doaj.org-article:d32ed25458984d0984e3aeaf961b65eb2021-11-22T01:11:32ZThe Ocular Surface Characteristics in Prostate Cancer Patients Treated with Androgen Deprivation Therapy1875-863010.1155/2021/5390195https://doaj.org/article/d32ed25458984d0984e3aeaf961b65eb2021-01-01T00:00:00Zhttp://dx.doi.org/10.1155/2021/5390195https://doaj.org/toc/1875-8630Background.To investigate the association of long-term androgen deprivation therapy (ADT) with ocular surface characteristics in prostate cancer patients. Methods. A total of 30 male prostate cancer patients who received ADT were selected. All candidates were scored using the Ocular Surface Disease Index (OSDI) and subsequently divided into two groups containing 9 symptomatic patients (scores >12) and 21 asymptomatic patients (scores≤12). Another 20 healthy age-matched males were selected as the control group. Each candidate was assessed with respect to eyelid margin abnormality, tear film break-up time (NI-BUT), tear meniscus height (TMH), meiboscore, meibum expressibility, and demodex infection. Results. The NI-BUT in the ADT group was significantly shorter than that in the control group. The scores for OSDI, eyelid margin abnormality, meibum expressibility, and meiboscores were significantly higher in the ADT group (P<0.05). Moreover, the NI-BUT in the symptomatic ADT group was significantly shorter than that in the asymptomatic ADT group (P<0.05). The meiboscores and meibum expressibility score in the symptomatic ADT group were significantly higher than those in the asymptomatic ADT group (P<0.05). The presence of demodex in the symptomatic ADT group was also higher than that in the asymptomatic ADT group (P<0.05).The length of time that patients had been taking ADT was positively correlated with meiboscores and negatively correlated with NI-BUT. Conclusion. Androgen levels were associated with significant changes in relative meibomian gland function. Subjective symptoms, such as dryness and foreign body sensation, were more obvious in prostate cancer patients receiving ADT, which may be caused by MGD and demodex infection. It’s recommended that more attention be paid to the ocular surface in prostate cancer patients taking ADT by performing examination of NI-BUT and meibomian gland morphology and function with a view to providing more comprehensive prevention and treatment protocols.Weina LiXiaofeng LiFeilun CuiZhipeng XuNuo DongCheng LiHindawi LimitedarticleMedicine (General)R5-920ENDisease Markers, Vol 2021 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine (General)
R5-920
spellingShingle Medicine (General)
R5-920
Weina Li
Xiaofeng Li
Feilun Cui
Zhipeng Xu
Nuo Dong
Cheng Li
The Ocular Surface Characteristics in Prostate Cancer Patients Treated with Androgen Deprivation Therapy
description Background.To investigate the association of long-term androgen deprivation therapy (ADT) with ocular surface characteristics in prostate cancer patients. Methods. A total of 30 male prostate cancer patients who received ADT were selected. All candidates were scored using the Ocular Surface Disease Index (OSDI) and subsequently divided into two groups containing 9 symptomatic patients (scores >12) and 21 asymptomatic patients (scores≤12). Another 20 healthy age-matched males were selected as the control group. Each candidate was assessed with respect to eyelid margin abnormality, tear film break-up time (NI-BUT), tear meniscus height (TMH), meiboscore, meibum expressibility, and demodex infection. Results. The NI-BUT in the ADT group was significantly shorter than that in the control group. The scores for OSDI, eyelid margin abnormality, meibum expressibility, and meiboscores were significantly higher in the ADT group (P<0.05). Moreover, the NI-BUT in the symptomatic ADT group was significantly shorter than that in the asymptomatic ADT group (P<0.05). The meiboscores and meibum expressibility score in the symptomatic ADT group were significantly higher than those in the asymptomatic ADT group (P<0.05). The presence of demodex in the symptomatic ADT group was also higher than that in the asymptomatic ADT group (P<0.05).The length of time that patients had been taking ADT was positively correlated with meiboscores and negatively correlated with NI-BUT. Conclusion. Androgen levels were associated with significant changes in relative meibomian gland function. Subjective symptoms, such as dryness and foreign body sensation, were more obvious in prostate cancer patients receiving ADT, which may be caused by MGD and demodex infection. It’s recommended that more attention be paid to the ocular surface in prostate cancer patients taking ADT by performing examination of NI-BUT and meibomian gland morphology and function with a view to providing more comprehensive prevention and treatment protocols.
format article
author Weina Li
Xiaofeng Li
Feilun Cui
Zhipeng Xu
Nuo Dong
Cheng Li
author_facet Weina Li
Xiaofeng Li
Feilun Cui
Zhipeng Xu
Nuo Dong
Cheng Li
author_sort Weina Li
title The Ocular Surface Characteristics in Prostate Cancer Patients Treated with Androgen Deprivation Therapy
title_short The Ocular Surface Characteristics in Prostate Cancer Patients Treated with Androgen Deprivation Therapy
title_full The Ocular Surface Characteristics in Prostate Cancer Patients Treated with Androgen Deprivation Therapy
title_fullStr The Ocular Surface Characteristics in Prostate Cancer Patients Treated with Androgen Deprivation Therapy
title_full_unstemmed The Ocular Surface Characteristics in Prostate Cancer Patients Treated with Androgen Deprivation Therapy
title_sort ocular surface characteristics in prostate cancer patients treated with androgen deprivation therapy
publisher Hindawi Limited
publishDate 2021
url https://doaj.org/article/d32ed25458984d0984e3aeaf961b65eb
work_keys_str_mv AT weinali theocularsurfacecharacteristicsinprostatecancerpatientstreatedwithandrogendeprivationtherapy
AT xiaofengli theocularsurfacecharacteristicsinprostatecancerpatientstreatedwithandrogendeprivationtherapy
AT feiluncui theocularsurfacecharacteristicsinprostatecancerpatientstreatedwithandrogendeprivationtherapy
AT zhipengxu theocularsurfacecharacteristicsinprostatecancerpatientstreatedwithandrogendeprivationtherapy
AT nuodong theocularsurfacecharacteristicsinprostatecancerpatientstreatedwithandrogendeprivationtherapy
AT chengli theocularsurfacecharacteristicsinprostatecancerpatientstreatedwithandrogendeprivationtherapy
AT weinali ocularsurfacecharacteristicsinprostatecancerpatientstreatedwithandrogendeprivationtherapy
AT xiaofengli ocularsurfacecharacteristicsinprostatecancerpatientstreatedwithandrogendeprivationtherapy
AT feiluncui ocularsurfacecharacteristicsinprostatecancerpatientstreatedwithandrogendeprivationtherapy
AT zhipengxu ocularsurfacecharacteristicsinprostatecancerpatientstreatedwithandrogendeprivationtherapy
AT nuodong ocularsurfacecharacteristicsinprostatecancerpatientstreatedwithandrogendeprivationtherapy
AT chengli ocularsurfacecharacteristicsinprostatecancerpatientstreatedwithandrogendeprivationtherapy
_version_ 1718418309869731840